Overview

Efficacy and Safety of Telmisartan Compared With Losartan

Status:
RECRUITING
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension
Phase:
PHASE4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Losartan
Telmisartan